Market Tracker

07/26 12:31pm ET

Rxi Pharmaceuticals Corp (NASDAQ:RXII)

0.6448
Delayed Data
As of 11:57am ET
 +0.0144 / +2.28%
Today’s Change
0.51
Today|||52-Week Range
2.93
-9.78%
Year-to-Date
No recent news for Rxi Pharmaceuticals Corp.

Today’s Trading

Previous close0.63
Today’s open0.63
Day’s range0.63 - 0.65
Volume28,828
Average volume (3 months)574,293
Market cap$13.9M
Dividend yield--
Data as of 11:57am ET, 07/26/2017

Growth & Valuation

Earnings growth (last year)+21.90%
Earnings growth (this year)+44.46%
Earnings growth (next 5 years)--
Revenue growth (last year)-44.12%
P/E ratioNM
Price/Sales253.76
Price/Book1.12

Competitors

 Today’s
change
Today’s
% change
GENEGenetic Technologies...+0.00+0.23%
XTNTXtant Medical Holdin...-0.01-0.63%
NDRAENDRA Life Sciences ...0.000.00%
IGCIndia Globalization ...-0.03-6.71%
Data as of 12:30pm ET, 07/26/2017

Financials

Next reporting dateAugust 17, 2017
EPS forecast (this quarter)-$0.20
Annual revenue (last year)$19.0K
Annual profit (last year)-$9.0M
Net profit margin-47,336.84%

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO, CFO &
Director
Geert Cauwenbergh
Vice President-
Research
Karen Bulock
Corporate headquarters
Marlborough, Massachusetts

Forecasts